The current evidence regarding the prevalence of subclinical carotid atherosclerosis (SCA) for people living with HIV(PLWH) is inconsistent. In this study, we aimed to synthesize data on the prevalence and association of SCA patients with HIV infection. We searched PubMed, EMBASE, Web of Science, Medline, SinoMed, and CNKI from inception to March 2, 2020. The pooled proportion, odds ratio (OR) with 95% confidence intervals (CIs) were calculated. For inclusion, SCA was measured by carotid intima-media thickness (CIMT), with a B-mode ultrasound machine. Twenty-six studies consisting of 6590 participants were identified. The overall prevalence of SCA was 31.6% (95% CI 13.4‐53.3; I2 = 99%; 4 studies) according to CIMT ≥ 0.78 mm criteria, and 32.3% (19.6‐46.4; 97%; 10 studies) according to CIMT ≥ 0.90 mm criteria. SCA prevalence was higher in Europe, over 40 years old and male. What’s more, PLWH have a higher likelihood of developing SCA comorbidity than HIV-negative controls (pooled OR 2.66, 95% CI 1.57‐4.50, I2 = 74%; 9 studies), even after sensitivity analysis (pooled OR 2.58, 1.54‐4.31, 73%). This study suggests a high prevalence and risk of SCA in the global population with HIV. As a result, subclinical carotid atherosclerosis deserves more attention from policymakers, HIV health-care providers, researchers, and stakeholders.
ShahASVStelzleDLeeKK, et al.Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation2018; 138: 1100–1112. DOI: 10.1161/circulationaha.117.033369.
2.
MathersCDLoncarD. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med2006; 3: e442. DOI: 10.1371/journal.pmed.0030442.
3.
TriantVALeeHHadiganC, et al.Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab2007; 92(7): 2506–2512. DOI: 10.1210/jc.2006-2190.
4.
LiBXiaYHuB. Infection and atherosclerosis: TLR-dependent pathways. Cell Mol Life Sci2020; 77(14): 2751–2769. DOI: 10.1007/s00018-020-03453-7.
5.
FaustOAcharyaURSudarshanVK, et al.Computer aided diagnosis of coronary artery disease, myocardial infarction and carotid atherosclerosis using ultrasound images: a review. Phys Med2017; 33: 1–15. DOI: 10.1016/j.ejmp.2016.12.005.
6.
SchoepfICBuechelRRKovariH, et al.Subclinical atherosclerosis imaging in people living with HIV. J of Clin Med2019; 8(8): 1125.
7.
LorenzMWMarkusHSBotsML, et al.Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation2007; 115: 459–467. DOI: 10.1161/circulationaha.106.628875.
8.
TouboulPJHennericiMGMeairsS, et al.Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis2012; 34: 290–296. DOI: 10.1159/000343145.
9.
SchmidtCFagerbergBWikstrandJ, et al.Multiple risk factor intervention reduces cardiovascular risk in hypertensive patients with echolucent plaques in the carotid artery. J Intern Med2003; 253: 430–438. DOI: 10.1046/j.1365-2796.2003.01129.x.
10.
AlbuquerqueVMZirpoliJCde Barros Miranda-FilhoD, et al.Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case-control study. BMC Infect Dis2013; 13: 274. DOI: 10.1186/1471-2334-13-274.
11.
SiwamogsathamSChutinetAVongsayanP, et al.Low CD4 cell counts are associated with carotid plaque and intima-media thickness in virologically suppressed HIV-infected asians older than 50 years. AIDS Res Hum Retroviruses2019; 35: 1160–1169. DOI: 10.1089/AID.2019.0126.
12.
MoherDShamseerLClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev2015; 4(1): 1. DOI: 10.1186/2046-4053-4-1.
13.
ZhanYLiuXFengY, et al.Safety and efficacy of human papillomavirus vaccination for people living with HIV: a systematic review and meta-analysis. Int J STD AIDS2019; 30: 1105–1115. DOI: 10.1177/0956462419852224.
HoyDBrooksPWoolfA, et al.Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J of Clin Epidemiol2012; 65: 934–939. DOI: 10.1016/j.jclinepi.2011.11.014.
16.
de GrootEHovinghGKWiegmanA, et al.Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation2004; 109(Suppl 1): Iii33-Iii38. DOI: 10.1161/01.CIR.0000131516.65699.
17.
SimonAMegnienJLChironiG. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler, Thromb Vasc Biol2010; 30: 182–185. DOI: 10.1161/atvbaha.109.196980.
18.
BarendregtJJDoiSALeeYY, et al.Meta-analysis of prevalence. J Epidemiol Community Health2013; 67(11): 974–978. DOI: 10.1136/jech-2013-203104.
19.
DuvalSTweedieR. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics2000; 56: 455–463. DOI: 10.1111/j.0006-341x.2000.00455.x.
20.
BellasiARaggiPRossiR, et al.Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients. Atherosclerosis2014; 237: 618–622. DOI: 10.1016/j.atherosclerosis.2014.10.017.
21.
BergmannTSenguptaSBhrushundiMP, et al.HIV related stigma, perceived social support and risk of premature atherosclerosis in South Asians. Indian Heart J2018; 70: 630–636. DOI: 10.1016/j.ihj.2018.06.018.
22.
BernalEMartinezMTorresA, et al.T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors. Antivir Res2019; 162: 163–170. DOI: 10.1016/j.antiviral.2018.12.014.
23.
CalzaLBorderiMGranozziB, et al.Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy. HIV Res Clin Pract2019; 20: 131–139. DOI: 10.1080/25787489.2020.1724749.
24.
D'AbramoAZingaropoliMAOlivaA, et al.Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. Mediators Inflamm2014; 2014: 192594. DOI: 10.1155/2014/192594.
25.
De SocioGVMartinelliCRicciE, et al.Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study. Int J STD AIDS2010; 21: 267–272. DOI: 10.1258/ijsa.2009.009165.
26.
FabbianiMCiccarelliNTanaM, et al.Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med2013; 14: 136–144. DOI: 10.1111/j.1468-1293.2012.01044.x.
27.
FalconeELMangiliATangAM, et al.Micronutrient concentrations and subclinical atherosclerosis in adults with HIV. Am J Clin Nutr2010; 91: 1213–1219. DOI: 10.3945/ajcn.2009.28816.
28.
GodoiETBrandtCTLacerdaHR, et al.Intima-media thickness in the carotid and femoral arteries for detection of arteriosclerosis in human immunodeficiency virus-positive individuals. Arq Bras Cardiol2017; 108: 3–11. DOI: 10.5935/abc.20160197.
29.
JeongSJSongJEKimSB, et al.Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy. AIDS Res Hum Retroviruses2013; 29: 1575–1581. DOI: 10.1089/AID.2013.0048.
30.
JericoCKnobelHCalvoN, et al.Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke2006; 37: 812–817. DOI: 10.1161/01.STR.0000204037.26797.7f.
31.
LeonRReusSLopezN, et al.Subclinical atherosclerosis in low Framingham risk HIV patients. Eur J Clin Invest2017; 47: 591–599. DOI: 10.1111/eci.12780.
32.
LinHDingYNingC, et al.Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort. The Lancet HIV2019; 6: e860-e868. DOI: 10.1016/s2352-3018(19)30263-2.
33.
MosepeleMHemphillLCMoloiW, et al.Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls. PloS One2017; 12: e0179994. DOI: 10.1371/journal.pone.0179994.
34.
ParraSCollBAragonesG, et al.Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation. HIV Med2010; 11: 225–231. DOI: 10.1111/j.1468-1293.2009.00766.x.
35.
PirsMErzenBSabovicM, et al.Early atherosclerosis in HIV-infected patients below the age of 55 years: Slovenian national study. Wien Klin Wochenschr2014; 126: 263–269. DOI: 10.1007/s00508-014-0516-6.
36.
SarfoFSNicholsMAgyeiB, et al.Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana. J Neurol Sci2019; 397: 103–111. DOI: 10.1016/j.jns.2018.12.026.
37.
SchoffelenAFde GrootETempelmanHA, et al.Carotid intima media thickness in mainly female HIV-infected subjects in rural South Africa: association with cardiovascular but not HIV-related factors. Clin Infect Dis2015; 61(10): 1606–1614. DOI: 10.1093/cid/civ586.
38.
SchwengerKJPArendtBMSmiejaM, et al.Relationships between atherosclerosis and plasma antioxidant micronutrients or red blood cell polyunsaturated fatty acids in people living with HIV. Nutrients2019; 11: 07. DOI: 10.3390/nu11061292.
39.
Serrano-VillarSEstradaVGomez-GarreD, et al.Incipient renal impairment as a predictor of subclinical atherosclerosis in HIV-infected patients. J Acquir Immune Defic Syndr (1999)2012; 59: 141–148. DOI: 10.1097/QAI.0b013e3182414366.
40.
SsinabulyaIKayimaJLongeneckerC, et al.Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda. PloS One2014; 9: e89537. DOI: 10.1371/journal.pone.0089537.
41.
ViskovicKRutherfordGWSudarioG, et al.Ultrasound measurements of carotid intima-media thickness and plaque in HIV-infected patients on the Mediterranean diet. Croat Med J2013; 54: 330–338. DOI: 10.3325/cmj.2013.54.330.
42.
YildizSSCetinSKeskinK, et al.Pregnancy-associated plasma protein-a is associated with subclinical atherosclerosis in men with HIV infection. J Investig Med2019; 67: 821–825. DOI: 10.1136/jim-2018-000859.
43.
ZizzaAGuidoMTumoloMR, et al.Atherosclerosis is associated with a higher risk of hepatic steatosis in HIV-infected patients. J Prev Med Hyg2017; 58: E219–E224.
44.
WHO. SDG Health and Health-Related Targets. (2015. accessd 9 June, 2020).
45.
RothGAJohnsonCAbajobirA, et al.Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol2017; 70: 1–25. DOI: 10.1016/j.jacc.2017.04.052.
46.
PutcharoenOPleumkanitkulSChutinetA, et al.Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand. J Virus Erad2019; 5: 23–27.
47.
SalmazoPSBazanSGZShiraishiFG, et al.Frequency of subclinical atherosclerosis in brazilian HIV-infected patients. Arq Bras Cardiol2018; 110: 402–410. DOI: 10.5935/abc.20180058.
48.
VosAGHoeveKBarthRE, et al.Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment. Retrovirology2019; 16: 37. DOI: 10.1186/s12977-019-0497-7.
49.
WuMYLiCJHouMF, et al.New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci2017; 18: 2034. DOI: 10.3390/ijms18102034.
50.
TeramotoT. [Significance and management of hyperlipemia as a risk factor for the progression of arteriosclerosis]. Nihon Naika Gakkai Zasshi2005; 94: 416–422. DOI: 10.2169/naika.94.416.
51.
ShimamotoK. [Hypertension as a risk factor for arteriosclerosis--a lesson from recent, large-scale clinical tests]. Nihon Naika Gakkai Zasshi2005; 94: 423–427. DOI: 10.2169/naika.94.423.
52.
BarakatMGAroraRR. Coronary artery disease in the human immunodeficiency virus seropositive population. Am J Ther2016; 23: e224-231. DOI: 10.1097/MJT.0b013e3182973924.
53.
JashariFIbrahimiPNicollR, et al.Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis2013; 227: 193–200. DOI: 10.1016/j.atherosclerosis.2012.11.008.
54.
DuJWassermanBATongW, et al.Cholesterol is associated with the presence of a lipid core in carotid plaque of asymptomatic, young-to-middle-aged African Americans with and without HIV infection and cocaine use residing in inner-city Baltimore, MD, USA. Cerebrovasc Dis2012; 33: 295–301. DOI: 10.1159/000334661.
55.
SchoepfICBuechelRRKovariH, et al.Subclinical atherosclerosis imaging in people living with HIV. J Clin Med2019; 8(8): 1125. DOI: 10.3390/jcm8081125.
56.
MerlinoBSalcuniMSaluteL, et al.Total body MR angiography and atherosclerosis. Rays2001; 26: 305–314.
57.
LongeneckerCTJiangYOrringerCE, et al.Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS2014; 28: 969–977. DOI: 10.1097/QAD.0000000000000158.
58.
AurpibulLSrithanaviboonchaiKRerkasemK, et al.Prevalence of subclinical atherosclerosis and risk of atherosclerotic cardiovascular disease in older adults living with HIV. AIDS Res Hum Retroviruses2019; 35: 1136–1142. DOI: 10.1089/AID.2019.0023.
59.
EckardARRaggiPRuffJH, et al.Arterial stiffness in HIV-infected youth and associations with HIV-related variables. Virulence2017; 8: 1265–1273. DOI: 10.1080/21505594.2017.1305533.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
